The latest price target for Nevro (NYSE:NVRO) was reported by Canaccord Genuity on February 7, 2025. The analyst firm set a price target for $5.85 expecting NVRO to rise to within 12 months (a possible 1.74% upside). 34 analyst firms have reported ratings in the last year.

The latest analyst rating for Nevro (NYSE:NVRO) was provided by Canaccord Genuity, and Nevro maintained their hold rating.

The last upgrade for Nevro Corp happened on February 7, 2025 when Piper Sandler raised their price target to $5.85. Piper Sandler previously had an underweight for Nevro Corp.

The last downgrade for Nevro Corp happened on December 2, 2024 when Morgan Stanley changed their price target from $9 to $4 for Nevro Corp.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Nevro, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Nevro was filed on February 7, 2025 so you should expect the next rating to be made available sometime around February 7, 2026.

While ratings are subjective and will change, the latest Nevro (NVRO) rating was a maintained with a price target of $4.00 to $5.85. The current price Nevro (NVRO) is trading at is $5.75, which is within the analyst’s predicted range.